CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Life Sciences Review | Wednesday, August 03, 2022
Tweet

The likelihood of success for compounds entering late-stage clinical development will increase with patient segmentation.


FREMONT, CA: Protypia, Inc., a company based in Nashville, Tennessee, is acquired by Inotiv, Inc. (the "Company," "We," or "Our," or "Inotiv"). Leading nonclinical and analytical drug discovery and development services, research models, and associated goods and services are the focus of Inotiv, Inc., a contract research business. This top contract research organization specializes in nonclinical and analytical drug discovery and development services, research models, and related products and services. Protypia is an up-and-coming protein/peptide bioanalytical firm providing high-quality, tissue-based peptide mass spectrometry and protein.


"This highly-specialized technology and know-how significantly enhances our ability to support clients in the development of safe and effective medicines, particularly in the areas of immuno-oncology and cell and gene therapy. 


The ability to precisely quantify protein levels in tissues, including paraffin-embedded tissues, opens exciting new avenues for scientists to explore as they investigate disease pathways." says John Sagartz, Chief Strategy Officer of Inotiv.


The estimated $11.0 million transactions were roughly $9.5 million in cash, approximately $0.9 million worth of Inotiv common shares, and $0.6 million in unsecured subordinated promissory notes. The business plans to keep all current Protypia personnel on board and continue business in Nashville, Tennessee. The Company's products and services are designed to speed up, improve data quality, and lower the price of bringing novel medicines to market while advancing the development of new medications and medical devices through the discovery and preclinical stages.


Inotiv is dedicated to assisting researchers in realizing the full potential of their important R&D projects while supporting their goals for discovery and development. All of this is done while collaborating to create a safer and healthier society.


Weekly Brief

loading
Top 10 Preeminent Cros – 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Achieving trial master file quality, timeliness and completeness

Susan K. Maue, Designation : Managing Director PharmaLex

Antibodies: The Building Blocks of Cures

John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma

The Dynamic Commercial Aspects of Life Sciences

Jim Cooper, Director, Clinical Operations, Moderna

The Future of Life Sciences Industry

Matthew (Matt) Hewitt, Executive Director, Scientific Solutions C and GT, Charles River

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Mark Mintz, Chief Information Officer at Charles River Laboratories

Re-imagining Learning in a Post-Pandemic World

Sebastian Teo, Head of Learning & Talent Management, Linde

Gene Therapy Clearly Communicated: The Importance of Patient-Centricity, Anan Omnichannel Approach, and Health Literacy

Tara Moroz, PhD Sr. Director, Genetic Medicine and Early Pipeline, Pfizer Inc.

Discovering the Medicines of the Future

Araz Raoof, Senior Vice President Global Drug Discovery & External Innovation at Ferring Pharmaceuticals
Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/protypia-inc-s-acquisition-by-inotiv-inc-broadens-the-company-s-proteinpeptide-bioanalytical-capabilities-nwid-934.html